Advertisement

Pulmonalvenenisolation zur Behandlung von Vorhofflimmern. Für wen, welche Methode, mit welchen Ergebnissen?

  • G. Nölker
  • Johannes Brachmann
Übersichten
  • 292 Downloads

Zusammenfassung

Vorhofflimmern stellt ein wesentliches Gesundheitsproblem der westlichen Welt dar. Neben der langjährig angewandten, zumeist medikamentös/konservativen Therapie, hat die Behandlung von Vorhofflimmern durch Ablationsbehandlung mit Isolation der Pulmonalvenen einen festen Platz in der aktuellen therapeutischen Strategie erlangt. Die neue Stellung der Methode wird durch aktualisierte Leitlinien der europäischen und der amerikanischen Fachgesellschaften untermauert.

Dieser Artikel stellt die Pulmonalvenenisolation unter besonderer Berücksichtigung der angewandten Methoden inklusive intrakardialem Ultraschall, sowie der möglichen Komplikationen, Erfolgsraten und der Nachbeobachtungsstrategien dar. Die Anwendung der Pulmonalvenenisolation bei Patienten mit Herzinsuffizienz und Vorhofflimmern wird gesondert diskutiert.

Schlüsselwörter

Pulmonalvenenisolation Herzinsuffizienz intrakardialer Ultraschall Komplikationen Nachuntersuchungen 

Pulmonary vein isolation in treatment of atrial fibrillation – Strategies, results and complications

Abstract

Atrial fibrillation is a relevant challenge for health care systems in Europe and North America. Interventional treatment of atrial fibrillation in terms of ablation of atrial structures including isolation of the pulmonary veins is nowadays established as an alternative to drug therapy, especially if treatment with antiarrhythmic drugs has been ineffective. Recently published European and North American guidelines support this strategy.

This article describes different techniques of atrial fibrillation ablation including intracardiac echo-guided pulmonary vein isolation. Potential complications, success rates and different follow-up strategies are specified. Furthermore interventional treatment of atrial fibrillation of heart failure patients is discussed.

Keywords

pulmonary vein isolation congestive heart failure intracardiac echocardiography complications follow-up 

Literaturangaben

  1. 1.
    Antz M; Ernst S, Ouyang F, et al: High intensity focused ultrasound for pulmonary vein antrum isolation - First clinical experience with a novel steerable balloon catheter. Heart Rhythm, Volume 2, Issue 5, Pages S63–S64 MGoogle Scholar
  2. 2.
    Arthur W, Kaye GC (2001) Tachyarrhythmia an heart failure. J Clin and Basic Cardiol 4 (Issue2), 115–122Google Scholar
  3. 3.
    Brand FN, Abbott RD, Kannel WB, et al. (1985) Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the framingham study. JAMA 254:3449–53PubMedCrossRefGoogle Scholar
  4. 4.
    Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. Heart Rhythm, Vol 4, No 6, June 2007Google Scholar
  5. 5.
    Cappato R, Calkins H, et al. (2005) Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 111:1100–1105.)PubMedCrossRefGoogle Scholar
  6. 6.
    Evans W, Swann P. (1954) Lone auricular fibrillation. Br Heart J 16:194CrossRefGoogle Scholar
  7. 7.
    Feinberg WM, Blackshear JL, Laupacis A, et al. (1995) Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 155:469–73PubMedCrossRefGoogle Scholar
  8. 8.
    Furberg CD, Psaty BM, Manolio TA, et al. (1994) Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular health study). Am J Cardiol 74:236–41PubMedCrossRefGoogle Scholar
  9. 9.
    Fuster et al. JACC Vol. 48, No. 4, 2006 ACC/AHA/ESC Practice Guidelines August 15, 2006:e149–246Google Scholar
  10. 10.
    Go AS, Hylek EM, Phillips KA, et al. (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk factors in atrial fibrillation (ATRIA) Study. JAMA 285:2370–5PubMedCrossRefGoogle Scholar
  11. 11.
    Haissaguerre M, Jais P, Shah DC, et al. (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–66PubMedCrossRefGoogle Scholar
  12. 12.
    Haissaguerre M, Shah DC, Jais P, et al. (2000) Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 102:2463–5PubMedGoogle Scholar
  13. 13.
    Hsu LF, Jaïs P, Haïssaguerre M et al. (2007) Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 351;23:2373–2383Google Scholar
  14. 14.
    Kopecky SL, Gersh BJ, McGoon MD, et al. (1987) The natural history of lone atrial fibrillation. A population-based study over three decades. N Engl J Med 317:669–74Google Scholar
  15. 15.
    Krahn AD, Manfreda J, Tate RB, et al. (1995) The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 98:476–84PubMedCrossRefGoogle Scholar
  16. 16.
    Mesas CE, Pappone C, Lang CC, et al. (2004) Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: electroanatomic characterization and treatment. J Am Coll Cardiol 44:1071–9PubMedCrossRefGoogle Scholar
  17. 17.
    Nademanee K, McKenzie J, Kosar E, et al. (2004) A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 43:2044–53PubMedCrossRefGoogle Scholar
  18. 18.
    Nieuwlaat R, Capucci A, Camm AJ, et al. (2005) Atrial fibrillation management: a prospective survey in ESC member countries: the euro heart survey on atrial fibrillation. Eur Heart J 26:2422–34PubMedCrossRefGoogle Scholar
  19. 19.
    Nölker G, Marschang H, Gutleben KJ et al. (2007) Three-dimensional left atrial and oesophagus reconstruction using cardiac C-Arm computed tomography for ablation of atrial fibrillation: preliminary experience. Circulation 116 II 365Google Scholar
  20. 20.
    Packer DL, Asirvatham S, Munger TM. (2003) Progress in nonpharmacologic therapy of atrial fibrillation. J Cardiovasc Electrophysiol 14:S296–S309CrossRefGoogle Scholar
  21. 21.
    Pappone C, Rosanio S, Oreto G, et al. (2000) Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation 102:2619–28PubMedGoogle Scholar
  22. 22.
    Pappone C, Santinelli V. (2004) The who, what, why, and how-to guide for circumferential pulmonary vein ablation. J Cardiovasc Electrophysiol 15:1226–30PubMedCrossRefGoogle Scholar
  23. 23.
    Piorkowski C, Kottkamp H, Tanner H et al: J Cardiovasc Electrophysiol, Vol 16, pp. 1286–1297Google Scholar
  24. 24.
    Reant et al. (2005) Remodeling after ablation for atrial fibrillation. Circulation 112:2896–2903Google Scholar
  25. 25.
    Ren JF, Marchlinski FE, Callans DJ, et al. (2005) Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast. J Cardiovasc Electrophysiol 16:474–7PubMedCrossRefGoogle Scholar
  26. 26.
    Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials [published erratum appears in Arch Intern Med 1994;154:2254]. Arch Intern Med 1994;154:1449–57Google Scholar
  27. 27.
    Scanavacca MI, D’avila A, Parga J, et al. (2004) Left atrial-esophageal fistula following radiofrequency catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 15:960–2PubMedGoogle Scholar
  28. 28.
    Stewart S, Hart CL, Hole DJ, et al. (2002) A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 113:359–64PubMedCrossRefGoogle Scholar
  29. 29.
    Verma A, Marrouche NF, Natale A. (2004) Pulmonary vein antrum isolation: intracardiac echocardiography-guided technique. J Cardiovasc Electrophysiol 15:1335–40PubMedCrossRefGoogle Scholar
  30. 30.
    Wattigney WA, Mensah GA, Croft JB. (2003) Increasing trends in hospitalisation for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation 108:711–6PubMedCrossRefGoogle Scholar
  31. 31.
    Wazni OM, Marrouche NF, Martin DO, et al. (2005) Radiofrequency ablation vs. antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 293:2634–40PubMedCrossRefGoogle Scholar

Copyright information

© Spinger 2008

Authors and Affiliations

  1. 1.Medizinische Klinik IIKlinikum CoburgCoburgDeutschland
  2. 2.Klink für Kardiologie, Angiologie und PulmonologieKlinikum CoburgCoburgDeutschland

Personalised recommendations